Amrutanjan Health Care Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 14.90% vs 4.92% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 1.04% vs 10.32% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 7.84% vs 8.21% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -16.67% vs 20.00% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Amrutanjan Healt With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

141.04

349.00

-207.96

-59.59%

Other Operating Income

0.00

Total Operating income

141.04

349.00

-207.96

-59.59%

Raw Material Cost

28.77

175.71

-146.94

-83.63%

Purchase of Finished goods

33.29

2.72

30.57

1,123.90%

(Increase) / Decrease In Stocks

1.73

8.17

-6.44

-78.82%

Employee Cost

16.15

55.23

-39.08

-70.76%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

21.34

0.00

21.34

Other Expenses

14.59

69.82

-55.23

-79.10%

Total Expenditure (Excl Depreciation)

115.87

311.65

-195.78

-62.82%

Operating Profit (PBDIT) excl Other Income

25.17

37.35

-12.18

-32.61%

Other Income

4.12

0.00

4.12

Operating Profit (PBDIT)

29.29

37.35

-8.06

-21.58%

Interest

0.05

22.45

-22.40

-99.78%

Exceptional Items

-1.25

-6.75

5.50

81.48%

Gross Profit (PBDT)

27.99

8.15

19.84

243.44%

Depreciation

1.62

25.57

-23.95

-93.66%

Profit Before Tax

26.36

-17.42

43.78

251.32%

Tax

6.91

0.00

6.91

Provisions and contingencies

0.00

Profit After Tax

19.45

-17.42

36.87

211.65%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

19.45

-17.42

36.87

211.65%

Equity Capital

2.89

44.49

-41.60

-93.50%

Face Value

1.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

6.73

-3.92

10.65

271.68%

Diluted Earnings per share

6.73

-3.97

10.70

269.52%

Operating Profit Margin (Excl OI)

17.85%

10.70%

0.00

7.15%

Gross Profit Margin

19.85%

2.34%

0.00

17.51%

PAT Margin

13.79%

-4.99%

0.00

18.78%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 141.04 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 19.83% vs 25.15% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 14.90% vs 4.92% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 19.45 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 39.33% vs 67.99% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 1.04% vs 10.32% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 25.17 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 52.27% vs 95.62% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 7.84% vs 8.21% in Dec 2024

Quarterly - Interest

Interest 0.05 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -16.67% vs 20.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 17.85%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024